The Role of Thymomas in the Development of Myasthenia Gravis

Authors

  • ALEXANDER MARX,

    Corresponding author
    1. Institute of Pathology, University of Würzburg, D-97080 Würzburg, Germany
      Address for correspondence: Alexander Marx, Institute of Pathology, University of Würzburg, Josef-Schneider-Strasse 2, D-97080 Würzburg, Germany. Voice: +49-931-201-47421; fax: +49-931-201-47505. path031@mail.uni-wuerzburg.deorpath036@mail.uni-wuerzburg.de
    Search for more papers by this author
  • HANS KONRAD MÜLLER-HERMELINK,

    1. Institute of Pathology, University of Würzburg, D-97080 Würzburg, Germany
    Search for more papers by this author
  • PHILIPP STRÖBEL

    1. Institute of Pathology, University of Würzburg, D-97080 Würzburg, Germany
    Search for more papers by this author

Address for correspondence: Alexander Marx, Institute of Pathology, University of Würzburg, Josef-Schneider-Strasse 2, D-97080 Würzburg, Germany. Voice: +49-931-201-47421; fax: +49-931-201-47505. path031@mail.uni-wuerzburg.deorpath036@mail.uni-wuerzburg.de

Abstract

Abstract: Thymic pathology occurs in 80–90% of myasthenia gravis patients. Significant associations between different thymic alterations and clinical findings are discussed. To highlight peculiarities in thymoma-associated myasthenia gravis, we briefly review myasthenia gravis associated with thymic lymphofollicular hyperplasia (TFH) and thymic atrophy.

Ancillary